Biocept Inc (BIOC) - Medical Equipment - Deals and Alliances Profile

Date: February 8, 2018
Pages: 64
Price:
US$ 250.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: B796D7BF985EN
Leaflet:

Download PDF Leaflet

Biocept Inc (BIOC) - Medical Equipment - Deals and Alliances Profile
Summary

Biocept Inc (Biocept) is a developer of diagnostic solutions. The company provides biopharmaceutical and clinical research, and molecular oncology laboratory services. It provides tests for various solid tumor cancers. Biocept offers related instrumentation, OncoCEE technology, and analytical capabilities for rare event detection and genetic characterization. The company’s OncoCEE platform modifies rare cell capture and analyses methods. It offers patented methodology to isolate rare cells including circulating tumor cells, and cell-free circulating tumor DNA from the blood. The company also develops methodology to isolate cancer material including circulating tumor cells, and cell-free circulating tumor DNA. It serves medical and surgical oncologists, pathologists, hospitals, cancer centers, universities, and pharmaceutical and clinical researchers. Biocept is headquartered in San Diego, California, the US.

Biocept Inc (BIOC) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope
  • Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
  • Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
  • Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
  • Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
  • Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
  • Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
  • Business Description - A brief description of the company's operations.
  • Key Employees - A list of the key executives of the company.
  • Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
  • Key Competitors - A list of the key competitors of the company.
  • Key Recent Developments - A brief on recent news about the company.
Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
  • The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
  • The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
  • Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
  • The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
  • Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
  • Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company.

NOTE: Out of security concerns GlobalData requires using corporate email address.
Biocept Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018
Biocept Inc, Medical Equipment Deals By Type, 2012 to YTD 2018
Biocept Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018
Biocept Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018
Biocept Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018
Biocept Inc, Medical Equipment, Deal Details
Partnerships
Biocept Enters into Marketing Agreement with Miraca Life Sciences
Biocept Enters into Agreement with University of Texas Southwestern Medical Center
Addario Lung Cancer Medical Institute and Biocept Enter into Partnership
Biocept Enters into Agreement with OHSU Knight Cancer Institute
Biocept Enters into Agreement with Catalyst Pharma
Biocept Enters into Agreement with Teneovita Medical Innovations
Biocept Forms Partnership with MedStar Georgetown University Hospital
Biocept to Form Partnership with Quest Diagnostics Mexico
Biocept Enters into Agreement
Biocept Enters into Distribution Agreement with Progenetics
Biocept Enters into Co-Development Agreement with Baylor College of Medicine
Biocept Enters into Partnership with Life Technologies
Equity Offering
Biocept Raises USD14.8 Million in Public Offering of Shares and Warrants
Biocept Prices Public Offering of Shares for USD3.3 Million
Biocept Prices USD3.3 Million in Public Offering of Shares
Biocept Plans to Raise Funds through Private Placement of Shares
Biocept to Raise USD2.2 Million in Private Placement of Shares and Warrants
Biocept Prices Private Placement of Shares and Warrants for USD9.3 Million
Biocept Raises USD10 Million in Public Offering of Shares and Warrants
Biocept Prices Public Offering of Shares and Warrants for USD5 Million
Biocept to Raise USD15 Million in Public Offering of Shares
Biocept Raises USD10 Million in Public Offering of Shares and Warrants
Biocept Completes IPO For US$19 Million
Biocept Raises USD2 Million in Private Placement of Series A Preferred Stock
Biocept Inc - Key Competitors
Biocept Inc - Key Employees
Biocept Inc - Locations And Subsidiaries
Head Office
Recent Developments
Financial Announcements
Nov 09, 2017: Biocept Reports Third Quarter 2017 Financial Results
Aug 10, 2017: Biocept Reports Second Quarter 2017 Financial Results
May 11, 2017: Biocept Reports First Quarter 2017 Financial Results
Mar 07, 2017: Biocept Reports Fourth Quarter and Full Year 2016 Financial Results
Corporate Communications
Oct 11, 2017: Renowned Lung Cancer Expert Fred R. Hirsch, M.D., Ph.D. Joins Biocept's Clinical Advisory Board
Feb 15, 2017: Biocept Appoints Michael Terry Senior Vice President Commercial Operations
Government and Public Interest
Jan 30, 2018: Biocept Comments on Updated Consensus Medical Guidelines Recommending Liquid Biopsy for Profiling of Tumor Biomarkers to Assist with the Treatment of Patients with Lung Cancer
Product News
Feb 05, 2018: Biocept Receives Additional Patent Issuances in Three Major International Territories for its Target Selector Platform
Jan 04, 2018: Biocept Obtains Patent in Australia for its Molecular Biomarker Technology For the Detection of Cancer-Associated Mutations in Blood, Tissue, and Other Biological Sources
Dec 05, 2017: First U.S. Patent Issued for Biocept's Target Selector Oncogene Mutation Enrichment and Detection Liquid Biopsy ctDNA Platform
Other Significant Developments
Dec 18, 2017: Biocept Signs In-Network Provider Agreement with Wellmark Blue Cross Blue Shield Expanding Coverage for its Target Selector Platform in Iowa and South Dakota
Oct 18, 2017: Biocept Launches Pathology Partnership Initiative Expanding Access of Proprietary Liquid Biopsy Testing to Community Pathologists and Hospitals
Aug 14, 2017: Biocept Enters Into Exclusive Distribution Agreement with Global Laboratory Product Supplier VWR
Aug 07, 2017: Biocept Executes Preferred Provider Agreement with Scripps Health Plan Expanding Patient Coverage for its Liquid Biopsy Platform
Jun 21, 2017: Biocept and MediNcrease Health Plans Announce Provider Agreement Expanding Access to Liquid Biopsy Testing
Jan 10, 2017: Biocept Secures In-Network Provider Agreement with Blue Cross Blue Shield of Texas
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Biocept Inc, Medical Equipment, Key Facts, 2016
Biocept Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018
Biocept Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018
Biocept Inc, Medical Equipment Deals By Type, 2012 to YTD 2018
Biocept Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018
Biocept Inc, Deals By Market, 2012 to YTD 2018
Biocept Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018
Biocept Enters into Marketing Agreement with Miraca Life Sciences
Biocept Enters into Agreement with University of Texas Southwestern Medical Center
Addario Lung Cancer Medical Institute and Biocept Enter into Partnership
Biocept Enters into Agreement with OHSU Knight Cancer Institute
Biocept Enters into Agreement with Catalyst Pharma
Biocept Enters into Agreement with Teneovita Medical Innovations
Biocept Forms Partnership with MedStar Georgetown University Hospital
Biocept to Form Partnership with Quest Diagnostics Mexico
Biocept Enters into Agreement
Biocept Enters into Distribution Agreement with Progenetics
Biocept Enters into Co-Development Agreement with Baylor College of Medicine
Biocept Enters into Partnership with Life Technologies
Biocept Raises USD14.8 Million in Public Offering of Shares and Warrants
Biocept Prices Public Offering of Shares for USD3.3 Million
Biocept Prices USD3.3 Million in Public Offering of Shares
Biocept Plans to Raise Funds through Private Placement of Shares
Biocept to Raise USD2.2 Million in Private Placement of Shares and Warrants
Biocept Prices Private Placement of Shares and Warrants for USD9.3 Million
Biocept Raises USD10 Million in Public Offering of Shares and Warrants
Biocept Prices Public Offering of Shares and Warrants for USD5 Million
Biocept to Raise USD15 Million in Public Offering of Shares
Biocept Raises USD10 Million in Public Offering of Shares and Warrants
Biocept Completes IPO For US$19 Million
Biocept Raises USD2 Million in Private Placement of Series A Preferred Stock
Biocept Inc, Key Competitors
Biocept Inc, Key Employees

LIST OF FIGURES

Biocept Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018
Biocept Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018
Biocept Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018
Biocept Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018
Biocept Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018
Biocept Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018
Biocept Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018
Biocept Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018
Skip to top


Ask Your Question

Biocept Inc (BIOC) - Medical Equipment - Deals and Alliances Profile
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: